Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0001193125-26-047535

Director acquired 8,713,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fairmount Funds Management LLC Director 2026-02-09 Option exercise +5,809,000 5,809,000 I
Fairmount Funds Management LLC Director 2026-02-09 Option exercise +2,904,000 2,904,000 I
Derivatives
Fairmount Funds Management LLC Director 2026-02-09 Option exercise · Series C Preferred Stock −5,809 1,148 I
Fairmount Funds Management LLC Director 2026-02-09 Option exercise · Series C Preferred Stock −2,904 574 I
Loading xslF345X05/ownership.xml…